Trokendi XR 50 mg/1 (Topiramate CAPSULE, EXTENDED RELEASE) 50 mg/1

Trokendi XR 50 mg/1 is an extended-release capsule containing topiramate, used for managing certain conditions. This medication is designed for oral administration and is manufactured by Supernus Pharmaceuticals in the USA.

Strength

50 mg/1

Pack Size

7 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-102-12)

Manufacturer / TM Owner

Supernus Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trokendi XR 50 mg/1 is generally used for the management of specific medical conditions. It is often prescribed for its extended-release properties, which can help maintain consistent levels of the active ingredient in the body. People may wonder, 'what is topiramate used for?' and it is typically utilized for conditions that require long-term management.

Side Effects

Common effects of Trokendi XR 50 mg/1 may include drowsiness, dizziness, and fatigue. Some individuals might experience changes in taste or appetite. These effects can vary from person to person and may not affect everyone in the same way.

Precautions & Warnings

Trokendi XR 50 mg/1 should be handled with care. It is important to follow the instructions provided by a healthcare professional. This medication should be stored at room temperature and kept out of reach of children. Always consult a healthcare provider before starting or stopping any medication.

Avoid Interactions

Trokendi XR 50 mg/1 may interact with other medications, including those that affect the central nervous system. Alcohol and certain other substances can also interact with topiramate. It is advisable to discuss all current medications and supplements with a healthcare provider to avoid potential interactions.

Frequently Asked Questions

Trokendi XR 50 mg/1 is generally used for managing certain medical conditions that require long-term treatment.

Trokendi XR 50 mg/1 is designed for oral administration and should be taken as directed by a healthcare professional.

Common effects may include drowsiness, dizziness, and fatigue, though these can vary from person to person.

Trokendi XR 50 mg/1 may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Trokendi XR 50 mg/1 should be stored at room temperature and kept out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.